434 related articles for article (PubMed ID: 18687985)
1. The role of Dickkopf-1 in bone development, homeostasis, and disease.
Pinzone JJ; Hall BM; Thudi NK; Vonau M; Qiang YW; Rosol TJ; Shaughnessy JD
Blood; 2009 Jan; 113(3):517-25. PubMed ID: 18687985
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
[TBL] [Abstract][Full Text] [Related]
4. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
5. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
[TBL] [Abstract][Full Text] [Related]
6. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.
Mariz K; Ingolf JB; Daniel H; Teresa NJ; Erich-Franz S
Clin Exp Metastasis; 2015 Dec; 32(8):857-66. PubMed ID: 26420587
[TBL] [Abstract][Full Text] [Related]
7. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation.
Clines GA; Mohammad KS; Bao Y; Stephens OW; Suva LJ; Shaughnessy JD; Fox JW; Chirgwin JM; Guise TA
Mol Endocrinol; 2007 Feb; 21(2):486-98. PubMed ID: 17068196
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss.
Wang FS; Ko JY; Yeh DW; Ke HC; Wu HL
Endocrinology; 2008 Apr; 149(4):1793-801. PubMed ID: 18174290
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
12. Fructus Ligustri Lucidi preserves bone quality through induction of canonical Wnt/β-catenin signaling pathway in ovariectomized rats.
Liu H; Guo Y; Zhu R; Wang L; Chen B; Tian Y; Li R; Ma R; Jia Q; Zhang H; Xia B; Li Y; Wang X; Zhu X; Zhang R; Brӧmme D; Gao S; Zhang D; Pei X
Phytother Res; 2021 Jan; 35(1):424-441. PubMed ID: 32755017
[TBL] [Abstract][Full Text] [Related]
13. Bone mass is inversely proportional to Dkk1 levels in mice.
MacDonald BT; Joiner DM; Oyserman SM; Sharma P; Goldstein SA; He X; Hauschka PV
Bone; 2007 Sep; 41(3):331-9. PubMed ID: 17613296
[TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1 has an Inhibitory Effect on Mesenchymal Stem Cells to Fibroblast Differentiation.
Li Y; Qiu SS; Shao Y; Song HH; Li GL; Lu W; Zhu LM
Chin Med J (Engl); 2016 May; 129(10):1200-7. PubMed ID: 27174329
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.
Heath DJ; Chantry AD; Buckle CH; Coulton L; Shaughnessy JD; Evans HR; Snowden JA; Stover DR; Vanderkerken K; Croucher PI
J Bone Miner Res; 2009 Mar; 24(3):425-36. PubMed ID: 19016584
[TBL] [Abstract][Full Text] [Related]
16. Multi-Targeting DKK1 and LRP6 Prevents Bone Loss and Improves Fracture Resistance in Multiple Myeloma.
Simic MK; Mohanty ST; Xiao Y; Cheng TL; Taylor VE; Charlat O; Croucher PI; McDonald MM
J Bone Miner Res; 2023 Jun; 38(6):814-828. PubMed ID: 36987921
[TBL] [Abstract][Full Text] [Related]
17. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
[TBL] [Abstract][Full Text] [Related]
18. R-spondin 2 promotes osteoblastic differentiation of immature human periodontal ligament cells through the Wnt/β-catenin signaling pathway.
Arima M; Hasegawa D; Yoshida S; Mitarai H; Tomokiyo A; Hamano S; Sugii H; Wada N; Maeda H
J Periodontal Res; 2019 Apr; 54(2):143-153. PubMed ID: 30284717
[TBL] [Abstract][Full Text] [Related]
19. Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis.
Zhang W; Drake MT
Curr Osteoporos Rep; 2012 Mar; 10(1):93-100. PubMed ID: 22210558
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway.
Knobloch J; Shaughnessy JD; Rüther U
FASEB J; 2007 May; 21(7):1410-21. PubMed ID: 17283219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
